hospitalized patients. Numerous randomized controlled trials (RCTs) show that using
thromboprophylaxis in hospitalized patients at risk for VTE is safe, effective and cost‐
effective. Despite this, prophylactic therapies for VTE are underutilized. System‐wide
interventions may be more effective to improve the use of VTE prophylaxis than relying on
individual providers' prescribing behaviors. Objectives To assess the effects of interventions …